• Work With Us
    • Partnerships
      • We offer tailored partnerships to support and transform drug discovery.

        Every collaboration is a bespoke arrangement, meticulously designed to discover new compounds and targets in patient relevant disease models.

    • Services
      • MIMETAS offers flexible fee-for-service solutions for therapy prioritization, optimization, and de-risking of compounds.

        As an extension of your team, MIMETAS provides the expertise and resources needed for effective research and development.

    • OrganoReady®
      • Our OrganoReady program is made for you when you need defined assays in ADME.

        We guarantee OrganoReady performance according to specifications, in a fast and convenient sales transaction with a clear fee structure.

  • Resources & Support
    • Knowledge Center
      • Get inspired by peer-reviewed publications, webinars, whitepapers, app notes and more in our knowledge center.

    • Blogs
      • Giving you some food for thought. Read our blogs to learn more about 3D tissue culture, research backgrounds, developments, and its future outlook.
    • Case Studies
      • Get inspired by research done by our scientists, partners, and customers around the globe.

    • Webinars & Events
    • Applications
  • About MIMETAS
  • News
  • We offer tailored partnerships to support and transform drug discovery.

    Every collaboration is a bespoke arrangement, meticulously designed to discover new compounds and targets in patient relevant disease models.

  • MIMETAS offers flexible fee-for-service solutions for therapy prioritization, optimization, and de-risking of compounds.

    As an extension of your team, MIMETAS provides the expertise and resources needed for effective research and development.

  • Our OrganoReady program is made for you when you need defined assays in ADME.

    We guarantee OrganoReady performance according to specifications, in a fast and convenient sales transaction with a clear fee structure.

  • Get inspired by peer-reviewed publications, webinars, whitepapers, app notes and more in our knowledge center.

  • Giving you some food for thought. Read our blogs to learn more about 3D tissue culture, research backgrounds, developments, and its future outlook.
  • Get inspired by research done by our scientists, partners, and customers around the globe.

  • Learn about our mission, vision, the history of the company, and find out what we mean with MIMETAS-do.
open menu icon close menu icon
EN

A Novel BBB-on-a-Chip Model for Disease Modeling and High-throughput Barrier and Transport Studies

On-demand Webinar

The vasculature of the brain is made up of specialized endothelial cells that form a tight blood–brain barrier (BBB). This endothelial barrier protects the brain from harmful substances, ensuring a homeostatic environment for the central nervous system (CNS) and healthy brain functioning. Studying the BBB in vitro enables researchers to gain knowledge necessary to assess potential toxicity of novel compounds, where the use of more complex in vitro models with improved physiological relevance can aid the development of efficient therapies for neurological disorders.

MIMETAS Senior Scientist, Dr. Nienke Wevers, presents a 3D BBB-on-a-Chip developed in the OrganoPlate®, that combines fast, high-throughput readouts with human-relevant conditions, revolutionizing the way scientists study the BBB.


In this webinar, you will:

  • Learn about the development of a novel BBB model that incorporates primary human brain endothelial cells, expressing adherens and tight junction proteins.
  • Explore how the BBB model can be used for barrier studies and transport studies.
  • Explore the OrganoPlate® platform’s high throughput and compatibility with automation.
  • See the BBB model's potential for disease modeling and more complex co-culture models of the neurovascular unit

Register here

Speaker

Dr. Nienke Wevers, Senior Scientist at MIMETAS
Nienke studied Bio-Pharmaceutical Sciences at Leiden University and Neuroscience at the VU University of Amsterdam. She obtained her PhD in neurobiology and in vitro BBB modeling at Mimetas in collaboration with Prof. Elga de Vries (VU medical center Amsterdam). She is currently working as a senior scientist at Mimetas and heading the company’s CNS and BBB research.



Related publications


Cookies

‘May we use cookies?
Hi there! Thanks for visiting our website. We use cookies to keep track of our website statistics to optimize the user experience. We also use cookies for marketing purposes. You can set your preferences by selecting the options below. Terms of Use & Privacy Policy

Accept all
Accept selected
Decline all